#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Deafness neurosensory Skin angiosarcoma Cervix carcinoma Medulloblastoma ABO haemolytic disease of newborn Fibrodysplasia ossificans progressiva Haemophilia B with anti factor IX Marfan's syndrome Congenital hypotransferrinaemia Rectal cancer Haemophilia B without inhibitors Undifferentiated sarcoma Complex regional pain syndrome Neutropenia Malformation venous More trials…

    Learn about Rare Diseases

    Alagille syndrome – Treatment Synovial sarcoma recurrent – Diagnostics Uterine leiomyosarcoma – Trials in Disease Tuberous sclerosis complex – Basic Information Angiosarcoma recurrent Mantle cell lymphoma refractory – Basic Information Cystic fibrosis – Diagnostics Cystic fibrosis lung – Diagnostics Undifferentiated sarcoma – Life with Disease Piriformis syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rbl007.2 Ralinepag Patisiran Ropeginterferon Alfa-2B Specific Nucleic Acid Sna-Xfsc INCB123667 Enomimeran LY4170156 Elasomeran Itraconazole Dabrafenib Mesylate Birtamimab Burfiralimab Ceralasertib The-630 BENZYLPENICILLIN PROCAINE Nacystelyn Etrinabdione Lufepirsen SODIUM SELENITE PENTAHYDRATE More therapies…

    Learn about Your Condition

    Meniscus injury Liver disorder Arteriovenous graft thrombosis Anal fissure Vulvar dysplasia Dyskinesia Oropharyngeal cancer recurrent Sciatica Autoimmune disorder Cardiac failure acute Agitation Pulmonary sarcoidosis Follicular lymphoma stage III Exfoliation glaucoma Primary hypercholesterolaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. NZOZ „Pro Cordis” Sopockie Centrum Badań Kardiologicznych…

NZOZ „Pro Cordis” Sopockie Centrum Badań Kardiologicznych Paweł Miękus

Ul. Jana Jerzego Haffnera 12A, Sopot, 81-717, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

    Recruiting

    3 1
    Investigated Drugs:
    • ZILEBESIRAN
    Austria Belgium Bulgaria Czechia Denmark France +11

  • Study of PF-07328948 tablets compared to placebo in adults with heart failure to evaluate effects on symptoms and physical function

    Recruiting

    2 1
    Bulgaria Czechia France Hungary Poland Spain

  • Study on JTT-861 for Patients with Heart Failure with Reduced Ejection Fraction

    Not recruiting

    2 1
    Investigated Drugs:
    • Jtt-861 Monohydrochloride Dihydrate
    Bulgaria Czechia Poland Romania Spain

  • Study on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Type IIa hyperlipidaemia
    Investigated Drugs:
    • Enlicitide Chloride
    Denmark France Germany Hungary Italy The Netherlands +3

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!